• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HAT检测法:一种用于新冠病毒病的廉价、可靠且定量的即时检验血清学检测方法。

HAT-field: a cheap, robust and quantitative Point-of-care serological test for Covid-19.

作者信息

Joly Etienne, Maurel Ribes Agnès

机构信息

CNRS, Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, Toulouse 31000, France.

Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, 31000 Toulouse, France.

出版信息

Biol Methods Protoc. 2022 Nov 28;7(1):bpac026. doi: 10.1093/biomethods/bpac026. eCollection 2022.

DOI:10.1093/biomethods/bpac026
PMID:36457547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9620368/
Abstract

The haemagglutination test (HAT)-field protocol described here is an optimization of the recently published HAT, for the detection of antibodies directed against the receptor binding domain (RBD) of the SARS-Cov-2 virus. HAT and HAT-field are both based on haemagglutination triggered by a single reagent, the IH4-RBD recombinant protein. A sample of IH4-RBD sufficient for several thousand tests or a plasmid encoding IH4-RBD can be obtained from the authors of our first paper. Using titration of IH4-RBD, HAT-field now allows a quantitative assessment of antibody levels in a single step, using a few microliters of whole blood, such as can be obtained by finger prick, and requires only very simple disposable equipment. Because it is based on a single soluble reagent, the test can be adapted very simply and rapidly to detect antibodies against variants of the SARS-CoV-2, or conceivably against different pathogens. HAT-field appears well suited to provide quantitative assessments of the serological protection of populations as well as individuals, and given its very low cost, the stability of the IH4-RBD reagent in the adapted buffer and the simplicity of the procedure, could be deployed pretty much anywhere, including in the poorest countries and the most remote corners of the globe.

摘要

本文所述的血凝试验(HAT)现场检测方案是对最近发表的HAT的优化,用于检测针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒受体结合域(RBD)的抗体。HAT和HAT现场检测均基于由单一试剂IH4-RBD重组蛋白引发的血凝反应。可从我们第一篇论文的作者处获得足以进行数千次检测的IH4-RBD样本或编码IH4-RBD的质粒。通过对IH4-RBD进行滴定,HAT现场检测现在可以使用几滴全血(如通过手指针刺采集)在一步中对抗体水平进行定量评估,并且仅需要非常简单的一次性设备。由于它基于单一可溶性试剂,该检测可以非常简单和快速地进行调整,以检测针对SARS-CoV-2变体或可能针对不同病原体的抗体。HAT现场检测似乎非常适合对人群以及个体的血清学保护进行定量评估,并且鉴于其成本非常低、IH4-RBD试剂在适配缓冲液中的稳定性以及操作的简单性,几乎可以在任何地方使用,包括在最贫穷的国家和全球最偏远的角落。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/ffbe2d818fa8/bpac026f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/8e24409b5515/bpac026f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/c28938c93dba/bpac026f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/4dc94ee5cf7b/bpac026f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/ae9224535522/bpac026f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/3580ef7ac895/bpac026f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/37f96606cd67/bpac026f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/ffbe2d818fa8/bpac026f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/8e24409b5515/bpac026f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/c28938c93dba/bpac026f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/4dc94ee5cf7b/bpac026f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/ae9224535522/bpac026f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/3580ef7ac895/bpac026f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/37f96606cd67/bpac026f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/9709703/ffbe2d818fa8/bpac026f7.jpg

相似文献

1
HAT-field: a cheap, robust and quantitative Point-of-care serological test for Covid-19.HAT检测法:一种用于新冠病毒病的廉价、可靠且定量的即时检验血清学检测方法。
Biol Methods Protoc. 2022 Nov 28;7(1):bpac026. doi: 10.1093/biomethods/bpac026. eCollection 2022.
2
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.商业抗 SARS-CoV-2 受体结合域抗体检测与化学发光减少中和检测的相关性,以及对新兴变异体抗体的可能检测。
Microbiol Spectr. 2021 Dec 22;9(3):e0056021. doi: 10.1128/Spectrum.00560-21. Epub 2021 Dec 1.
3
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.临床实践中 SARS-CoV-2 抗体的血清学检测:一项比较诊断准确性研究。
Allergy. 2022 Jul;77(7):2090-2103. doi: 10.1111/all.15206. Epub 2022 Jan 11.
4
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.针对 SARS-CoV-2 刺突受体结合域和核衣壳的异源抗体及其对 COVID-19 免疫的影响。
JCI Insight. 2020 Sep 17;5(18):142386. doi: 10.1172/jci.insight.142386.
5
Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.日本对 BNT162b2 疫苗的抗体反应:通过测量针对 SARS-CoV-2 受体结合域的 IgG 抗体来监测疫苗效力。
Microbiol Spectr. 2022 Feb 23;10(1):e0118121. doi: 10.1128/spectrum.01181-21. Epub 2022 Jan 19.
6
Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region.移动实验室 B-LiFE 中 IgM 和 IgG 检测在 COVID-19 诊断中的诊断价值:皮埃蒙特大区的大规模检测策略。
Int J Environ Res Public Health. 2021 Mar 24;18(7):3372. doi: 10.3390/ijerph18073372.
7
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
8
Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.化学发光免疫分析检测疫苗接种和康复 COVID-19 队列中中和抗体和结合抗体的纵向分布。
Immun Inflamm Dis. 2022 Jun;10(6):e612. doi: 10.1002/iid3.612.
9
Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 Multi-Parameter Detection.新型 ELISA 方案将先前存在的 SARS-CoV-2 反应性抗体与地方性冠状病毒免疫力和年龄联系起来,并改进了急性 COVID-19 多参数检测的血清学鉴定。
Front Immunol. 2021 Apr 9;12:614676. doi: 10.3389/fimmu.2021.614676. eCollection 2021.
10
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.中和 SARS-CoV-2 需要针对构象受体结合域表位的抗体。
Allergy. 2022 Jan;77(1):230-242. doi: 10.1111/all.15066. Epub 2021 Sep 22.

本文引用的文献

1
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222.个体感染严重程度不同及接种一剂阿斯利康 AZD1222 后对 SARS-CoV-2 蛋白的免疫应答动力学
Clin Exp Immunol. 2022 Jun 23;208(3):323-331. doi: 10.1093/cei/uxac009.
2
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.一种用于预测对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变体免疫力的快速抗体筛查血凝试验。
Commun Med (Lond). 2022 Apr 5;2:36. doi: 10.1038/s43856-022-00091-x. eCollection 2022.
3
A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation.
基于血凝和人工智能解释的 SARS-CoV-2 抗体快速、廉价的即时检测方法。
Sci Rep. 2021 Dec 30;11(1):24507. doi: 10.1038/s41598-021-04298-1.
4
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka.斯里兰卡科伦坡市地区 SARS-CoV-2 感染的血清阳性率。
Front Public Health. 2021 Nov 12;9:724398. doi: 10.3389/fpubh.2021.724398. eCollection 2021.
5
The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.用于检测SARS-CoV-2免疫的抗体检测的科学缺陷。
JAMA. 2021 Nov 9;326(18):1781-1782. doi: 10.1001/jama.2021.18919.
6
A Hemagglutination-Based Semiquantitative Test for Point-of-Care Determination of SARS-CoV-2 Antibody Levels.基于血凝的即时检测用于 SARS-CoV-2 抗体水平的床边半定量检测。
J Clin Microbiol. 2021 Nov 18;59(12):e0118621. doi: 10.1128/JCM.01186-21. Epub 2021 Sep 1.
7
Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction.六种不同免疫测定法检测 SARS-CoV-2 抗体与恢复期血浆中中和抗体水平的可比性:从效用到预测。
Transfusion. 2021 Oct;61(10):2837-2843. doi: 10.1111/trf.16600. Epub 2021 Aug 17.
8
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.健康工作者单次接种 AZD1222/Covishield 疫苗的免疫应答。
Nat Commun. 2021 Jul 29;12(1):4617. doi: 10.1038/s41467-021-24579-7.
9
How to interpret and use COVID-19 serology and immunology tests.如何解读和使用 COVID-19 血清学和免疫学检测
Clin Microbiol Infect. 2021 Jul;27(7):981-986. doi: 10.1016/j.cmi.2021.05.001. Epub 2021 May 8.
10
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.一种用于快速检测 SARS-CoV-2 抗体的血凝试验。
Nat Commun. 2021 Mar 29;12(1):1951. doi: 10.1038/s41467-021-22045-y.